Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations

Coronavirus Disease 19 (COVID-19), due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has become an on-going global health emergency affecting over 94 million cases with more than 2 million deaths globally. Primarily identified as atypical pneumonia, it has developed into severe acu...

Full description

Bibliographic Details
Main Authors: Vikram Thakur, Radha Kanta Ratho, Pradeep Kumar, Shashi Kant Bhatia, Ishani Bora, Gursimran Kaur Mohi, Shailendra K Saxena, Manju Devi, Dhananjay Yadav, Sanjeet Mehariya
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/3/446
_version_ 1797407928693555200
author Vikram Thakur
Radha Kanta Ratho
Pradeep Kumar
Shashi Kant Bhatia
Ishani Bora
Gursimran Kaur Mohi
Shailendra K Saxena
Manju Devi
Dhananjay Yadav
Sanjeet Mehariya
author_facet Vikram Thakur
Radha Kanta Ratho
Pradeep Kumar
Shashi Kant Bhatia
Ishani Bora
Gursimran Kaur Mohi
Shailendra K Saxena
Manju Devi
Dhananjay Yadav
Sanjeet Mehariya
author_sort Vikram Thakur
collection DOAJ
description Coronavirus Disease 19 (COVID-19), due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has become an on-going global health emergency affecting over 94 million cases with more than 2 million deaths globally. Primarily identified as atypical pneumonia, it has developed into severe acute respiratory distress syndrome (ARDS), a multi-organ dysfunction with associated fatality. Ever since its emergence, COVID-19 with its plethora of clinical presentations has signalled its dynamic nature and versatility of the disease process. Being a disease with droplet transmission has now assumed the proportion of a suspected airborne nature which, once proved, poses a Herculean task to control. Because of the wide distribution of the human angiotensin-converting enzyme-2 (hACE2) receptors, known for its transmission, we envisage its multiorgan spread and extensive disease distribution. Thus, an extensive review of the extrapulmonary organotropism of SARS-CoV-2 with organ-specific pathophysiology and associated manifestations like dermatological complications, myocardial dysfunction, gastrointestinal symptoms, neurologic illnesses, hepatic and renal injury is needed urgently. The plausible mechanism of site-specific viral invasion is also discussed to give a comprehensive understanding of disease complexity, to help us to focus on research priorities and therapeutic strategies to counter the disease progression. A note on the latest advancements in vaccine research will enlighten the scientific world and equip it for better preparedness.
first_indexed 2024-03-09T03:49:52Z
format Article
id doaj.art-ce16f0076d874fe0b3ac8d2f646fe5aa
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-09T03:49:52Z
publishDate 2021-01-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-ce16f0076d874fe0b3ac8d2f646fe5aa2023-12-03T14:29:36ZengMDPI AGJournal of Clinical Medicine2077-03832021-01-0110344610.3390/jcm10030446Multi-Organ Involvement in COVID-19: Beyond Pulmonary ManifestationsVikram Thakur0Radha Kanta Ratho1Pradeep Kumar2Shashi Kant Bhatia3Ishani Bora4Gursimran Kaur Mohi5Shailendra K Saxena6Manju Devi7Dhananjay Yadav8Sanjeet Mehariya9Department of Virology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, IndiaDepartment of Virology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, IndiaFaculty of Applied Sciences and Biotechnology, Shoolini University of Biotechnology and Management Sciences, Solan 173229, IndiaDepartment of Biological Engineering, College of Engineering, Konkuk University, Seoul 05029, KoreaDepartment of Virology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, IndiaDepartment of Virology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, IndiaCentre for Advanced Research, Faculty of Medicine, King George’s Medical University, Lucknow 226003, IndiaDepartment of Oral Pathology and Microbiology, RUHS College of Dental Sciences (Government Dental College), RUHS University of Rajasthan, Jaipur, Rajasthan 302016, IndiaDepartment of Medical Biotechnology, Yeungnam University, Gyeongsan 712-749, KoreaDepartment of Engineering, University of Campania ‘Luigi Vanitelli’, Real Casa dell’ Annunziata, Via Roma 29, 81031 Aversa, ItalyCoronavirus Disease 19 (COVID-19), due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has become an on-going global health emergency affecting over 94 million cases with more than 2 million deaths globally. Primarily identified as atypical pneumonia, it has developed into severe acute respiratory distress syndrome (ARDS), a multi-organ dysfunction with associated fatality. Ever since its emergence, COVID-19 with its plethora of clinical presentations has signalled its dynamic nature and versatility of the disease process. Being a disease with droplet transmission has now assumed the proportion of a suspected airborne nature which, once proved, poses a Herculean task to control. Because of the wide distribution of the human angiotensin-converting enzyme-2 (hACE2) receptors, known for its transmission, we envisage its multiorgan spread and extensive disease distribution. Thus, an extensive review of the extrapulmonary organotropism of SARS-CoV-2 with organ-specific pathophysiology and associated manifestations like dermatological complications, myocardial dysfunction, gastrointestinal symptoms, neurologic illnesses, hepatic and renal injury is needed urgently. The plausible mechanism of site-specific viral invasion is also discussed to give a comprehensive understanding of disease complexity, to help us to focus on research priorities and therapeutic strategies to counter the disease progression. A note on the latest advancements in vaccine research will enlighten the scientific world and equip it for better preparedness.https://www.mdpi.com/2077-0383/10/3/446SARS-CoV-2COVID-19ACE-2neurologicalhepaticdermatological
spellingShingle Vikram Thakur
Radha Kanta Ratho
Pradeep Kumar
Shashi Kant Bhatia
Ishani Bora
Gursimran Kaur Mohi
Shailendra K Saxena
Manju Devi
Dhananjay Yadav
Sanjeet Mehariya
Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations
Journal of Clinical Medicine
SARS-CoV-2
COVID-19
ACE-2
neurological
hepatic
dermatological
title Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations
title_full Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations
title_fullStr Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations
title_full_unstemmed Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations
title_short Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations
title_sort multi organ involvement in covid 19 beyond pulmonary manifestations
topic SARS-CoV-2
COVID-19
ACE-2
neurological
hepatic
dermatological
url https://www.mdpi.com/2077-0383/10/3/446
work_keys_str_mv AT vikramthakur multiorganinvolvementincovid19beyondpulmonarymanifestations
AT radhakantaratho multiorganinvolvementincovid19beyondpulmonarymanifestations
AT pradeepkumar multiorganinvolvementincovid19beyondpulmonarymanifestations
AT shashikantbhatia multiorganinvolvementincovid19beyondpulmonarymanifestations
AT ishanibora multiorganinvolvementincovid19beyondpulmonarymanifestations
AT gursimrankaurmohi multiorganinvolvementincovid19beyondpulmonarymanifestations
AT shailendraksaxena multiorganinvolvementincovid19beyondpulmonarymanifestations
AT manjudevi multiorganinvolvementincovid19beyondpulmonarymanifestations
AT dhananjayyadav multiorganinvolvementincovid19beyondpulmonarymanifestations
AT sanjeetmehariya multiorganinvolvementincovid19beyondpulmonarymanifestations